相关实验视频

Updated: Jun 5, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌的分子和免疫景观用于治疗开发

Hiroyuki Suzuki¹, Sumit Mishra¹, Subhojit Paul¹

¹Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Journal of liver cancer

|December 5, 2024

概括

肝细胞癌 (HCC) 治疗正在通过向药物和免疫疗法取得进展. 识别分子标和使用生物标志物旨在个性化护理并改善HCC患者的治疗结果.

科学领域:

肝细胞癌 (HCC) 研究研究
分子瘤学分子瘤学
癌症免疫疗法癌症免疫疗法

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
目前的向和免疫疗法在先进的HCC中表现出局限性,尚未广泛应用于早期阶段.
了解瘤微环境中的分子异常是治疗策略的关键.

研究的目的:

审查最近分子向药物和HCC的免疫治疗方法的进展.
探索以前无法治疗的点和已知的HCC标志物作为治疗点的潜力.
讨论生物标志物在指导个性化治疗和HCC临床试验设计中的作用.

主要方法:

对确定HCC分子异常的omics分析研究的审查.
对新兴治疗点的分析,包括TERT促进体和TP53突变.
检查与HCC相关的标记物 (α-fetoprotein,glypican-3,上皮细胞粘附分子) 作为目标.
讨论包含预测生物标志物的新型临床试验设计.

主要成果:

像TERT促进体和TP53突变这样的反复发生的分子异常正在被探索为新的治疗标.
已建立的HCC标志物也正在研究治疗向.
生物标志物对于识别可能从特定疗法中受益的患者至关重要,优化治疗疗效.
提出了创新的临床试验设计,以有效评估新的HCC药物.

结论:

个性化分子向疗法对改善HCC患者预后具有重大前景.
整合omics数据,新目标和预测生物标志物的整合对于临床翻译至关重要.
需要有效的临床试验设计来评估在HCC中越来越多的新治疗剂.

关键词:

临床试验的设计肝细胞癌是肝细胞癌.分子向疗法分子向疗法预测性生物标志物预测性生物标志物

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...